The funding supports development of an assay to detect and differentiate H5 influenza A from seasonal H1 and H3 subtypes, flu B, and COVID-19.

We spoke with endocrinologists to explore the potential of artificial intelligence in the management of chronic disease, including diabetes, obesity, and PCOS.

The funding supports development of an assay to detect and differentiate H5 influenza A from seasonal H1 and H3 subtypes, flu B, and COVID-19.

Dr. Ed Boas of City of Hope explores how advanced 3D printing is rewriting the rulebook for medical device innovation and ...

Yes, the state superintendent appears to have had female nudity on display via his office TV, but also, under his leadership, ...

The poet John Dryden wrote, “Words are but pictures of our thoughts,” and a couple of new ones — pogonotomy and xylarium — recently roused some mental illustrations. A xylarium ...

"We try to watch our clients’ money, but these criminals of financial fraud and scams are skilled beyond belief,” said Ahmad ...

The ZeroTo510 accelerator is offering support including $25,000 investments and launching the Medical Device Operations ...

Jin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing Facility ...

Can a Medical Device Restore Your Balance? Nearly two million people worldwide have lost the simple ability to feel steady. Now researchers have developed an experimental medical implant that ...

NEW YORK (AP) — A federal judge in Texas removed a Biden-era finalized rule by the Consumer Financial Protection Bureau that would have removed medical debt from credit reports. U.S. District Court ...

Medical charity MSF accuses Ethiopian soldiers of ‘targeted killing’ of 3 staffers in Tigray in 2021 ...